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Response to Drs. Borges and Klompmaker
To the Editor; The insights of Doctors Borges and Klomp-
maker and their colleagues draw attention to one of the
unique differences between fibrolamellar hepatoma (FLH)
and the usual type of hepatocellular carcinoma (HCC): racial
or ethnic distribution. However, in my concluding remarks
(1), I less than precisely questioned why FLH is found only
in the United States. The observation I was attempting to
highlight was that HCC is most commonly found on the Far
East and in sub-Saharan Africa where it is responsible for
1,000,000 deaths annually (2). In contrast, FLH reports ap-
pear primarily among patients not originating or descending
from the endemic areas of HCC. Doctor Borges and colleagues
did highlight the few reported cases of FLH originating from
the endemic areas. However, one of these reported cases is of
a Belgium tourist in West Malaysia (3), not a resident of the
endemic population. I-LH appears to be found predominantly
among Caucasian populations not residing in the endemic
areas of HCC. This highlights the possible differences of
etiology, genetics, exposures, or pathogenesis between FLH
and HCC. Sumithron and Looi (4) have demonstrated race-
related morphologic variations in HCC between the Chinese
and Senoi aboriginal tribe in West Malaysia.
The case of FLH reported by Doctor Klompmaker and
colleagues serves to strengthen the need for an international
case registry. Such a data base is the only method to feasibly
answer the many questions about FLH and HCC.
Mack T. Ruffm, IV, M.D., M.P.H.
University of Michigan
Department of Family Practice
Ann Arbor, MI
REFERENCES
1. Ruffin MT. Fibrolamellar carcinoma. Am J Gastroenterol
1990;85:577-81.
2. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, et al. Hepatocellular
carcinoma. Ann Intern Med 1988; 108:390-401.
3. Sumithran E. Fibrolamellar carcinoma of the iner. Am J Clin
Pathol 1984;82:633-4 (letter).
Received Feb. 27. 1991; accepted Mar. 5, 1991.
Methicillin-Resistant Staphytococcus aureus (MRSA)
Enteritis Associated with Prophylactic Cephalosporin
Administration and Hypochlorhydria, after Suhtotal
Gastrectomy
To the Editor: Clostridium difficile pseudomembranous
colitis (SMC) (1, 2), diarrhea, and enterocolitis are well-
documented side-effects of antibiotic therapy. However, the
number of cases of postoperative methicillin-resistant Staph-
ylococcus aureus (MRSA) enterocolitis (3) among Japanese
patients who have undergone gastric resection and received a
third-generation cephalosporin has increased markedly since
1985 (4).
A 51-yr-old man presented with massive bleeding from
hemorrhagic gastritis. He had been a heavy smoker for 20 yr,
and his blood type was AB Rh(D) negative. After the failure
of conservative management, including hemostasis under en-
doscopic control, subtotal gastrectomy was perfonned. Pro-
phylaxis with cefazolin 3.0 g, three times a day, and an H2-
blocker were administered for 7 days postoperatively. During
this period, the patient developed a cough productive of
massive amounts of yellow-white sputum. Culture revealed
infection with |S-lactamase (+) methicillin-resistant S. aureus
and Pseudomonas aeruginosa. On the 8th postoperative day,
watery diarrhea developed, concomitant with initiation of
refeeding. The diarrhea consisted of fragile green flakes in
massive amounts of fecal fluid containing mucus (2600 ml
daily). Fecal culture was positive for the same strains of /3-
lactamase {+) methicillin-resistant S. aureus and P. aerugi-
nosa as recovered from the sputum. Proctosigmoidscopic
examination by flexible sigmoidscope did not reveal SMC.
The patient did not improve clinically until cefazolin was
discontinued and the antibiotic changed to minocycline sen-
sitive to the organisms cultured, despite the administration of
strong antidiarrheal agents (tincture of opium and codeine
phosphate).
Most patients with antimicrobial-associated enterocolitis
suffer from diarrhea, fever, and/or abdominal cramps. The
presentation of postoperative MRSA enterocolitis is similar.
This case suggests that gut flora can proliferate, regardless of
the generation of antibiotics, possibly resulting in colitis. In
such cases, MRSA enterocolitis may develop when microor-
ganisms from infected sputum are swallowed and are able to
proliferate because the pH in the gastric remnant is greater
than 5, with or without H2 blockade. MRSA has been shown
to be resistant to high pH gastric juice (5, 6). On the other
hand, Hori et al. (4) have demonstrated, in a nationwide
questionnaire survey on postoperative MRSA enterocolitis in
Japan from 1985 to 1989, that 82.9% of cases of postoperative
MRSA enterocolitis occurred in patients who had undergone
gastrectomy, and a cephalosporin had been administered in
all the cases. A strong correlation existed between MRSA
enterocolitis and the intravenous administration of third-
generation cephalosporins (25/35, 71.7%).

